medigraphic.com
ISSN 2594-1526 (Digital)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2020, Número 2

<< Anterior Siguiente >>

Neumol Cir Torax 2020; 79 (2)


COVID-19: recomendaciones generales y especificaciones para el paciente con cáncer de pulmón avanzado. Revisión de la literatura

Sánchez-Ríos CP, Ramírez-Candelas MÁ, Menchaca-Dávila SA, Martínez-Barrera LOM, Rodríguez-Cid JR, Alatorre-Alexander JA

Idioma: Español
Referencias bibliográficas: 25
Paginas: 101-109
Archivo PDF: 284.67 Kb.


RESUMEN

El brote de la nueva enfermedad por coronavirus 2019 (COVID-19) se ha convertido en una amenaza para la salud mundial. Sabemos que el riesgo de enfermedad grave y muerte en los casos de COVID-19 aumenta con la edad y la presencia de condiciones de salud comórbidas como obesidad, hipertensión arterial sistémica, diabetes mellitus, enfermedad pulmonar obstructiva crónica y estados de inmunosupresión como el cáncer. Desde la aparición del primer caso en Wuhan, China, en diciembre de 2019, se han llevado a cabo enormes esfuerzos de investigación para comprender los mecanismos de transmisibilidad y potenciales ofertas terapéuticas que impacten en las tasas de mortalidad. En esta revisión se plantean los potenciales desafíos del paciente infectado por COVID-19 y el cáncer pulmonar.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Perlman S, Netland J. Coronaviruses pos-SARS: Update on replication and pathogenesis. Nat Rev Microbiol 2009;7(6):439-450. https://doi.org/10.1038/nrmicro2147.

  2. Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 2013;21(10):544-555. https://doi.org/10.1016/j.tim.2013.05.005.

  3. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92(4):418-423. https://doi.org/10.1002/jmv.25681.

  4. Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020;9(1):221-236. https://doi.org/10.1080/22221751.2020.1719902.

  5. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199-1207. https://doi.org/10.1056/nejmoa2001316.

  6. Bauch ChT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: Past, present, and future. Epidemiology 2005;16(6):791-801. https://doi.org/10.1097/01.ede.0000181633.80269.4c.

  7. Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog 2018;14(8):e1007236. https://doi.org/10.1371/journal.ppat.1007236

  8. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J Med Virol 2020;92(6):584-588. https://doi.org/10.1002/jmv.25719.

  9. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patient with pneumoniain China, 2019. N Engl J Med 2020;382(8):727-733. https://doi.org/10.1056/nejmoa2001017.

  10. Zhou P, Yang XL, Wang XG, et al . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270-273.https://doi.org/10.1038/s41586-020-2012-7.

  11. Huang Ch, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5.

  12. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72?314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648.

  13. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, di Napoli R. Features, evaluation and treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing; 2020.

  14. Yoon SH, Lee KH, Kim JY, et al. Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean J Radiol 2020;21(4):494-500. https://doi.org/10.3348/kjr.2020.0132.

  15. Xu YH, Dong JH, An WM, et al. Clinical and computed tomography imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020;80(4):394-400. https://doi.org/10.1016/j.jinf.2020.02.017.

  16. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15(5):700-704. https://doi.org/10.1016/j.jtho.2020.02.010.

  17. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019;53(4):1802339. https://doi.org/10.1183/13993003.02339-2018.

  18. Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Götte M. The antiviral compound Remdesivir potently inhibits RNA-dependent RNA polymerase from middle east respiratory syndrome coronavirus. J Biol Chem 2020;295(15):4773-4779. https://doi.org/10.1074/jbc.ac120.013056.

  19. De Wit E, Feldmann F, Cronin J, et al. Prophylactic and therapeutic Remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 2020;117(12):6771-6776. https://doi.org/10.1073/pnas.1922083117.

  20. Asociación Médica China, Rama de Oncología de la Asociación Médica China; Revista de la Asociación Médica China. Guía de Diagnóstico Clínico y Tratamiento del Cáncer de Pulmón de la Asociación Médica China (Edición 2018). Chinese J Oncology 2018;40(12):935-964. https://doi.org/10.3760/cma.j.issn.0253-3766.2018.12.012.

  21. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21(3):335-337. https://doi.org/10.1016/s1470-2045(20)30096-6.

  22. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. New England Journal of Medicine 2020. doi: 10.1056/NEJMoa2002032

  23. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3.

  24. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481. Observational study. https://doi.org/10.1016/s2213-2600(20)30079-5.

  25. Zarogoulidis P, Kouliatsis G, Papanas N, et al. Long-term respiratory follow-up of H1N1 infection. Virol J 2011;8:319. https://doi.org/10.1186/1743-422x-8-319.




2020     |     www.medigraphic.com